Global Pharma 4.0 market growth is projected to reach  US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Pharma 4.0 Market Trends and Analysis 2025-31

The global Pharma 4.0 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Pharma 4.0 is a holistic operating model for pharmaceutical factories and supply chains of the future based on Industry 4.0 capabilities, digital maturity, and data integrity by design.Pharma 4.0 is a framework for adapting digital strategies to the unique contexts of pharmaceutical manufacturing. In practical terms, it means more connectivity, more productivity, simplified compliance, and the marshaling of production information to respond to problems as they emerge. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Pharma 4.0 Industry Forecast looks at past sales and reviews total world Pharma 4.0 sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharma 4.0 sales for 2025 through 2031. With Pharma 4.0 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharma 4.0 industry. This Insight Report provides a comprehensive analysis of the global Pharma 4.0 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Pharma 4.0 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Pharma 4.0 market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharma 4.0 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharma 4.0. This report presents a comprehensive overview, market shares, and growth opportunities of Pharma 4.0 market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Cloud &nbsp;&nbsp;&nbsp; On-premise Segmentation by Application: &nbsp;&nbsp;&nbsp; Pharmaceutical Industry &nbsp;&nbsp;&nbsp; IoT Industry &nbsp;&nbsp;&nbsp; Medical Equipment Industry &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Pfizer Inc &nbsp;&nbsp;&nbsp; Abbott Laboratories &nbsp;&nbsp;&nbsp; GE Healthcare &nbsp;&nbsp;&nbsp; Boston Scientific &nbsp;&nbsp;&nbsp; Medtronic Plc. &nbsp;&nbsp;&nbsp; Lonza Group AG &nbsp;&nbsp;&nbsp; GlaxoSmithKline plc. &nbsp;&nbsp;&nbsp; Koninklijke Philips N.V. &nbsp;&nbsp;&nbsp; Glatt GmbH &nbsp;&nbsp;&nbsp; Vertex &nbsp;&nbsp;&nbsp; Johnson & Johnson &nbsp;&nbsp;&nbsp; Goodly Innovations &nbsp;&nbsp;&nbsp; QbDVision &nbsp;&nbsp;&nbsp; Electrosan &nbsp;&nbsp;&nbsp; GoSilico &nbsp;&nbsp;&nbsp; Smart Factory &nbsp;&nbsp;&nbsp; Krber AG

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Pharma 4.0 Market Size (2020-2031) &nbsp;2.1.2 Pharma 4.0 Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Pharma 4.0 by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Pharma 4.0 Segment by Type &nbsp;2.2.1 Cloud &nbsp;2.2.2 On-premise &nbsp;2.3 Pharma 4.0 Market Size by Type &nbsp;2.3.1 Pharma 4.0 Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Pharma 4.0 Market Size Market Share by Type (2020-2025) &nbsp;2.4 Pharma 4.0 Segment by Application &nbsp;2.4.1 Pharmaceutical Industry &nbsp;2.4.2 IoT Industry &nbsp;2.4.3 Medical Equipment Industry &nbsp;2.4.4 Others &nbsp;2.5 Pharma 4.0 Market Size by Application &nbsp;2.5.1 Pharma 4.0 Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Pharma 4.0 Market Size Market Share by Application (2020-2025) 3 Pharma 4.0 Market Size by Player &nbsp;3.1 Pharma 4.0 Market Size Market Share by Player &nbsp;3.1.1 Global Pharma 4.0 Revenue by Player (2020-2025) &nbsp;3.1.2 Global Pharma 4.0 Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Pharma 4.0 Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Pharma 4.0 by Region &nbsp;4.1 Pharma 4.0 Market Size by Region (2020-2025) &nbsp;4.2 Global Pharma 4.0 Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Pharma 4.0 Market Size Growth (2020-2025) &nbsp;4.4 APAC Pharma 4.0 Market Size Growth (2020-2025) &nbsp;4.5 Europe Pharma 4.0 Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Pharma 4.0 Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Pharma 4.0 Market Size by Country (2020-2025) &nbsp;5.2 Americas Pharma 4.0 Market Size by Type (2020-2025) &nbsp;5.3 Americas Pharma 4.0 Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Pharma 4.0 Market Size by Region (2020-2025) &nbsp;6.2 APAC Pharma 4.0 Market Size by Type (2020-2025) &nbsp;6.3 APAC Pharma 4.0 Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Pharma 4.0 Market Size by Country (2020-2025) &nbsp;7.2 Europe Pharma 4.0 Market Size by Type (2020-2025) &nbsp;7.3 Europe Pharma 4.0 Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Pharma 4.0 by Region (2020-2025) &nbsp;8.2 Middle East & Africa Pharma 4.0 Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Pharma 4.0 Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Pharma 4.0 Market Forecast &nbsp;10.1 Global Pharma 4.0 Forecast by Region (2026-2031) &nbsp;10.1.1 Global Pharma 4.0 Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Pharma 4.0 Forecast &nbsp;10.1.3 APAC Pharma 4.0 Forecast &nbsp;10.1.4 Europe Pharma 4.0 Forecast &nbsp;10.1.5 Middle East & Africa Pharma 4.0 Forecast &nbsp;10.2 Americas Pharma 4.0 Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Pharma 4.0 Forecast &nbsp;10.2.2 Canada Market Pharma 4.0 Forecast &nbsp;10.2.3 Mexico Market Pharma 4.0 Forecast &nbsp;10.2.4 Brazil Market Pharma 4.0 Forecast &nbsp;10.3 APAC Pharma 4.0 Forecast by Region (2026-2031) &nbsp;10.3.1 China Pharma 4.0 Market Forecast &nbsp;10.3.2 Japan Market Pharma 4.0 Forecast &nbsp;10.3.3 Korea Market Pharma 4.0 Forecast &nbsp;10.3.4 Southeast Asia Market Pharma 4.0 Forecast &nbsp;10.3.5 India Market Pharma 4.0 Forecast &nbsp;10.3.6 Australia Market Pharma 4.0 Forecast &nbsp;10.4 Europe Pharma 4.0 Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Pharma 4.0 Forecast &nbsp;10.4.2 France Market Pharma 4.0 Forecast &nbsp;10.4.3 UK Market Pharma 4.0 Forecast &nbsp;10.4.4 Italy Market Pharma 4.0 Forecast &nbsp;10.4.5 Russia Market Pharma 4.0 Forecast &nbsp;10.5 Middle East & Africa Pharma 4.0 Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Pharma 4.0 Forecast &nbsp;10.5.2 South Africa Market Pharma 4.0 Forecast &nbsp;10.5.3 Israel Market Pharma 4.0 Forecast &nbsp;10.5.4 Turkey Market Pharma 4.0 Forecast &nbsp;10.6 Global Pharma 4.0 Forecast by Type (2026-2031) &nbsp;10.7 Global Pharma 4.0 Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Pharma 4.0 Forecast 11 Key Players Analysis &nbsp;11.1 Pfizer Inc &nbsp;11.1.1 Pfizer Inc Company Information &nbsp;11.1.2 Pfizer Inc Pharma 4.0 Product Offered &nbsp;11.1.3 Pfizer Inc Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Pfizer Inc Main Business Overview &nbsp;11.1.5 Pfizer Inc Latest Developments &nbsp;11.2 Abbott Laboratories &nbsp;11.2.1 Abbott Laboratories Company Information &nbsp;11.2.2 Abbott Laboratories Pharma 4.0 Product Offered &nbsp;11.2.3 Abbott Laboratories Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Abbott Laboratories Main Business Overview &nbsp;11.2.5 Abbott Laboratories Latest Developments &nbsp;11.3 GE Healthcare &nbsp;11.3.1 GE Healthcare Company Information &nbsp;11.3.2 GE Healthcare Pharma 4.0 Product Offered &nbsp;11.3.3 GE Healthcare Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 GE Healthcare Main Business Overview &nbsp;11.3.5 GE Healthcare Latest Developments &nbsp;11.4 Boston Scientific &nbsp;11.4.1 Boston Scientific Company Information &nbsp;11.4.2 Boston Scientific Pharma 4.0 Product Offered &nbsp;11.4.3 Boston Scientific Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Boston Scientific Main Business Overview &nbsp;11.4.5 Boston Scientific Latest Developments &nbsp;11.5 Medtronic Plc. &nbsp;11.5.1 Medtronic Plc. Company Information &nbsp;11.5.2 Medtronic Plc. Pharma 4.0 Product Offered &nbsp;11.5.3 Medtronic Plc. Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Medtronic Plc. Main Business Overview &nbsp;11.5.5 Medtronic Plc. Latest Developments &nbsp;11.6 Lonza Group AG &nbsp;11.6.1 Lonza Group AG Company Information &nbsp;11.6.2 Lonza Group AG Pharma 4.0 Product Offered &nbsp;11.6.3 Lonza Group AG Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Lonza Group AG Main Business Overview &nbsp;11.6.5 Lonza Group AG Latest Developments &nbsp;11.7 GlaxoSmithKline plc. &nbsp;11.7.1 GlaxoSmithKline plc. Company Information &nbsp;11.7.2 GlaxoSmithKline plc. Pharma 4.0 Product Offered &nbsp;11.7.3 GlaxoSmithKline plc. Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 GlaxoSmithKline plc. Main Business Overview &nbsp;11.7.5 GlaxoSmithKline plc. Latest Developments &nbsp;11.8 Koninklijke Philips N.V. &nbsp;11.8.1 Koninklijke Philips N.V. Company Information &nbsp;11.8.2 Koninklijke Philips N.V. Pharma 4.0 Product Offered &nbsp;11.8.3 Koninklijke Philips N.V. Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Koninklijke Philips N.V. Main Business Overview &nbsp;11.8.5 Koninklijke Philips N.V. Latest Developments &nbsp;11.9 Glatt GmbH &nbsp;11.9.1 Glatt GmbH Company Information &nbsp;11.9.2 Glatt GmbH Pharma 4.0 Product Offered &nbsp;11.9.3 Glatt GmbH Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Glatt GmbH Main Business Overview &nbsp;11.9.5 Glatt GmbH Latest Developments &nbsp;11.10 Vertex &nbsp;11.10.1 Vertex Company Information &nbsp;11.10.2 Vertex Pharma 4.0 Product Offered &nbsp;11.10.3 Vertex Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Vertex Main Business Overview &nbsp;11.10.5 Vertex Latest Developments &nbsp;11.11 Johnson & Johnson &nbsp;11.11.1 Johnson & Johnson Company Information &nbsp;11.11.2 Johnson & Johnson Pharma 4.0 Product Offered &nbsp;11.11.3 Johnson & Johnson Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.11.4 Johnson & Johnson Main Business Overview &nbsp;11.11.5 Johnson & Johnson Latest Developments &nbsp;11.12 Goodly Innovations &nbsp;11.12.1 Goodly Innovations Company Information &nbsp;11.12.2 Goodly Innovations Pharma 4.0 Product Offered &nbsp;11.12.3 Goodly Innovations Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.12.4 Goodly Innovations Main Business Overview &nbsp;11.12.5 Goodly Innovations Latest Developments &nbsp;11.13 QbDVision &nbsp;11.13.1 QbDVision Company Information &nbsp;11.13.2 QbDVision Pharma 4.0 Product Offered &nbsp;11.13.3 QbDVision Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.13.4 QbDVision Main Business Overview &nbsp;11.13.5 QbDVision Latest Developments &nbsp;11.14 Electrosan &nbsp;11.14.1 Electrosan Company Information &nbsp;11.14.2 Electrosan Pharma 4.0 Product Offered &nbsp;11.14.3 Electrosan Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.14.4 Electrosan Main Business Overview &nbsp;11.14.5 Electrosan Latest Developments &nbsp;11.15 GoSilico &nbsp;11.15.1 GoSilico Company Information &nbsp;11.15.2 GoSilico Pharma 4.0 Product Offered &nbsp;11.15.3 GoSilico Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.15.4 GoSilico Main Business Overview &nbsp;11.15.5 GoSilico Latest Developments &nbsp;11.16 Smart Factory &nbsp;11.16.1 Smart Factory Company Information &nbsp;11.16.2 Smart Factory Pharma 4.0 Product Offered &nbsp;11.16.3 Smart Factory Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.16.4 Smart Factory Main Business Overview &nbsp;11.16.5 Smart Factory Latest Developments &nbsp;11.17 K�rber AG &nbsp;11.17.1 K�rber AG Company Information &nbsp;11.17.2 K�rber AG Pharma 4.0 Product Offered &nbsp;11.17.3 K�rber AG Pharma 4.0 Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.17.4 K�rber AG Main Business Overview &nbsp;11.17.5 K�rber AG Latest Developments 12 Research Findings and Conclusion

Report	Global Pharma 4.0 Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI13909

Buyer Information

Order Summary